Healthcare - Biotechnology - NYSE - US
$ 6.37
-12.9 %
$ 367 M
Market Cap
-0.35
P/E
Price Target
Average
10.81%
Revenue Forecast
Estimate
12.05%
EBIT
Estimate
17.71%
Net Income
Estimate
34.75%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ginkgo Bioworks Holdings, Inc.
Wall Street analysts predict an average 1-year price target for DNA of $7.06 , with forecasts ranging from a low of $4.35 to a high of $12 .
DNA Lowest Price Target
Wall Street Target
4.35 USD
-31.71%
DNA Average Price Target
Wall Street Target
7.06 USD
10.81%
DNA Highest Price Target
Wall Street Target
12 USD
88.38%
REVENUE FORECAST
Revenue Forecast Chart DNA
EBIT FORECAST
EBIT Forecast Chart DNA
NET INCOME FORECAST
Net Income Chart DNA